Context Capital Management, LLC has filed its 13F form on November 12, 2025 for Q3 2025 where it was disclosed a total value porftolio of $14,000 distributed in 269 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Ftac Emerald Acquisition Corp. with a value of $8K, Celularity Inc Wt Exp 05/24/20 with a value of $6K, Pros Holdings Inc with a value of $0, Oyster Enterprises Ii Acquis with a value of $0, and Oyster Enterprises Ii Acquis with a value of $0.
Examining the 13F form we can see an decrease of $50K in the current position value, from $64K to 14K .
Also it can be appreciated an additional of 92 stocks purchases and 1 closed positions .
Below you can find more details about Context Capital Management, LLC portfolio as well as his latest detailed transactions.
Financial Services: $8,000
Healthcare: $6,000
Stock
Market Cap.
Holding Value (Reported)
# of Shares.
Last Trade
Trade History
-
$0
0.0% of portfolio
-
Q3 2025
New
Cantor Equity Partners Iv In
-
$0
0.0% of portfolio
-
Q3 2025
New
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 18.79%
Cardio Diagnostics Holdgs In
-
$0
0.0% of portfolio
-
Q1 2023
New
Cohen Circle Acquisit Corp I
-
$0
0.0% of portfolio
-
Q3 2025
New
Cohen Circle Acquisit Corp I
-
$0
0.0% of portfolio
-
Q3 2025
New
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 33.33%
Chenghe Acquisition Iii CO
-
$0
0.0% of portfolio
-
Q3 2025
New
Charlton Aria Acquisition CO
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q1 2024
Reduced 38.99%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 12.0%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 3.77%
Centurion Acquisition Corp
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q3 2025
New
-
$0
0.0% of portfolio
-
Q3 2023
New
Cartesian Growth Corp Iii
-
$0
0.0% of portfolio
-
Q2 2025
New
Cartesian Growth Corp Iii
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 23.86%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 5.2%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 3.85%
Applied Optoelectronics Inc
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 25.96%
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2025
New
-
$0
0.0% of portfolio
-
Q3 2025
New
-
$0
0.0% of portfolio
-
Q3 2025
Added 33.23%
Aa Mission Acquisition Corp
-
$0
0.0% of portfolio
-
Q4 2024
New
Aa Mission Acquisition Corp
-
$0
0.0% of portfolio
-
Q4 2024
New
Above Food Ingredients Inc
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 40.0%
-
$0
0.0% of portfolio
-
Q3 2025
New
-
$0
0.0% of portfolio
-
Q3 2025
New
Alchemy Invts Acquisitn Corp
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q2 2025
Added 34.43%
-
$0
0.0% of portfolio
-
Q2 2025
New
American Exceptionalism Acqu
-
$0
0.0% of portfolio
-
Q3 2025
New
Ares Management Corporation
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 38.46%
Armada Acquisition Corp Ii
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 12.5%
Armada Acquisition Corp Ii
-
$0
0.0% of portfolio
-
Q3 2025
Added 12.5%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 22.0%
-
$0
0.0% of portfolio
-
Q3 2025
Added 7.57%
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 16.67%
-
$0
0.0% of portfolio
-
Q2 2023
New
-
$0
0.0% of portfolio
-
Q4 2023
New
-
$0
0.0% of portfolio
-
Q3 2025
New
Axiom Intelligence Ac Corp 1
-
$0
0.0% of portfolio
-
Q3 2025
New
Axiom Intelligence Ac Corp 1
-
$0
0.0% of portfolio
-
Q3 2025
New
-
$0
0.0% of portfolio
-
Q3 2025
Added 3.64%
Aspire Biopharma Hldgs Inc
-
$0
0.0% of portfolio
-
Q1 2025
New
Artius Ii Acquisition Inc
-
$0
0.0% of portfolio
-
Q2 2025
New
Artius Ii Acquisition Inc
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 30.83%